Traditional methods of CCTA analysis preclude reporting the specific types of plaque indicative of adverse cardiac events when evaluating coronary disease. Substantial manual workup time, physician team disagreement and lack of standardization create a disjointed system. These factors often lead to inefficient diagnostic testing and poor patient outcomes.
Artrya Salix for Administrators
An enterprise solution that improves the diagnostic investigation of stable and acute chest pain patients
Major predictors of heart attack are overlooked during patient evaluations
Artrya Salix streamlines the diagnosis of chest pain for effective patient management
Artrya Salix delivers a new approach for collaborative diagnosis. From an easy-to-use web application, physicians can rapidly read and report CCTA scan interpretations that include important plaque features associated with heart attack risk.
